Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Elander NO"'
Autor:
Elander, NO, Aughton, K, Ghaneh, P, Neoptolemos, JP, Palmer, DH, Cox, TF, Campbell, F, Costello, E, Halloran, CM, Mackey, JR, Scarfe, AG, Valle, JW, McDonald, AC, Carter, R, Tebbutt, NC, Goldstein, D, Shannon, J, Dervenis, C, Glimelius, B, Deakin, M, Charnley, RM, Anthoney, A, Lerch, MM, Mayerle, J, Olah, A, Buchler, MW, Greenhalf, W, Canc, European Study Grp Pancreatic
Publikováno v:
British Journal of Cancer
Elander, N O, Aughton, K, Ghaneh, P, Neoptolemos, J P, Palmer, D H, Cox, T F, Campbell, F, Costello, E, Halloran, C M, Mackey, J R, Scarfe, A G, Valle, J W, McDonald, A C, Carter, R, Tebbutt, N C, Goldstein, D, Shannon, J, Dervenis, C, Glimelius, B, Deakin, M, Charnley, R M, Anthoney, A, Lerch, M M, Mayerle, J, Oláh, A, Büchler, M W & Greenhalf, W 2018, ' Intratumoural expression of deoxycytidylate deaminase or ribonuceotide reductase subunit M1 expression are not related to survival in patients with resected pancreatic cancer given adjuvant chemotherapy ', British Journal of Cancer, vol. 118, no. 8, pp. 1084-1088 . https://doi.org/10.1038/s41416-018-0005-1
Elander, N O, Aughton, K, Ghaneh, P, Neoptolemos, J P, Palmer, D H, Cox, T F, Campbell, F, Costello, E, Halloran, C M, Mackey, J R, Scarfe, A G, Valle, J W, McDonald, A C, Carter, R, Tebbutt, N C, Goldstein, D, Shannon, J, Dervenis, C, Glimelius, B, Deakin, M, Charnley, R M, Anthoney, A, Lerch, M M, Mayerle, J, Oláh, A, Büchler, M W & Greenhalf, W 2018, ' Intratumoural expression of deoxycytidylate deaminase or ribonuceotide reductase subunit M1 expression are not related to survival in patients with resected pancreatic cancer given adjuvant chemotherapy ', British Journal of Cancer, vol. 118, no. 8, pp. 1084-1088 . https://doi.org/10.1038/s41416-018-0005-1
Background: Deoxycytidylate deaminase (DCTD) and ribonucleotide reductase subunit M1 (RRM1) are potential prognostic and predictive biomarkers for pyrimidine-based chemotherapy in pancreatic adenocarcinoma. Methods: Immunohistochemical staining of DC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::790a22716d8573e23011c4425b535bac
Autor:
Almlöv K; Department of Surgery in Norrköping and Department of Biomedical and Clinical Sciences, Linköping University, Norrköping, Sweden. Electronic address: karin.almlov@liu.se., Arbman G; Department of Surgery in Norrköping and Department of Biomedical and Clinical Sciences, Linköping University, Norrköping, Sweden., Björnsson B; Department of Surgery in Linköping and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden., Elander NO; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden; Clatterbridge Cancer Centre NHS, FT, Liverpool, United Kingdom., Hager J; Department of Surgery in Norrköping and Department of Biomedical and Clinical Sciences, Linköping University, Norrköping, Sweden., Hamid S; Department of Surgery in Norrköping and Department of Biomedical and Clinical Sciences, Linköping University, Norrköping, Sweden., Landerholm K; Department of Surgery in Jönköping and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden., Loftås P; Department of Surgery in Linköping and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden., Sandström P; Department of Surgery in Linköping and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Publikováno v:
HPB : the official journal of the International Hepato Pancreato Biliary Association [HPB (Oxford)] 2024 Sep; Vol. 26 (9), pp. 1131-1140. Date of Electronic Publication: 2024 May 22.
Autor:
Hedvall P; Department of Physics, Stockholm University, AlbaNova University Center, SE-10691 Stockholm, Sweden., Hörnquist J; Department of Physics, Stockholm University, AlbaNova University Center, SE-10691 Stockholm, Sweden., Yakovlev SL; St. Petersburg State University, St. Petersburg, Russia., Elander NO; Department of Physics, Stockholm University, AlbaNova University Center, SE-10691 Stockholm, Sweden., Larson Å; Department of Physics, Stockholm University, AlbaNova University Center, SE-10691 Stockholm, Sweden.
Publikováno v:
The Journal of chemical physics [J Chem Phys] 2024 Aug 07; Vol. 161 (5).
Autor:
Wode K; Department of Radiation Sciences/Oncology, Umeå University, Umeå, Sweden; Department of Neurobiology, Caring Sciences and Society, Karolinska Institutet, Stockholm, Sweden; Regional Cancer Centre Stockholm Gotland, Stockholm, Sweden; Center for Complementary Medicine, Department of Medicine II, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Institute for Applied Epistemology and Medical Methodology at Witten/Herdecke University (IFAEMM), Freiburg, Germany; Department of Nursing, Umeå University, Umeå, Sweden; Department of Biomedical and Clinical Sciences, Linköping University, Sweden; Department of Oncology, Västmanlands Hospital, Västerås, Schweden; Department of Oncology, Ryhov County Hospital, Jönköping, Schweden; Palliative Care Unit Västerås, Schweden., Kienle GS, Björ O, Fransson P, Sharp L, Elander NO, Bernhardson BM, Johansson B, Edwinsdotter Ardnor C, Scheibling U, Hök Nordberg J, Henriksson R
Publikováno v:
Deutsches Arzteblatt international [Dtsch Arztebl Int] 2024 May 31; Vol. 121 (11), pp. 347-354.
Autor:
Blomstrand H; Department of Clinical Pathology, and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden. Electronic address: hakon.blomstrand@liu.se., Olsson H; Department of Clinical Pathology, and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden., Green H; Division of Clinical Chemistry and Pharmacology, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden; Department of Forensic Genetics and Forensic Toxicology, National Board of Forensic Medicine, Linköping, Sweden., Björnsson B; Department of Surgery, and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden., Elander NO; Department of Biomedical and Clinical Sciences, Linköping University, Sweden; Clatterbridge Cancer Centre NHS FT, Liverpool, United Kingdom.
Publikováno v:
HPB : the official journal of the International Hepato Pancreato Biliary Association [HPB (Oxford)] 2023 Dec; Vol. 25 (12), pp. 1531-1544. Date of Electronic Publication: 2023 Aug 18.
Autor:
Asowed M; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, 581 83, Sweden., Elander NO; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, 581 83, Sweden., Pettersson L; Department of Oncology, Ryhov County Hospital, Jönköping, 551 85, Sweden., Ekholm M; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, 581 83, Sweden.; Department of Oncology, Ryhov County Hospital, Jönköping, 551 85, Sweden., Papantoniou D; Department of Oncology, Ryhov County Hospital, Jönköping, 551 85, Sweden. dimitris.papantoniou@medsci.uu.se.; Department of Medical Sciences, Endocrine Oncology, Uppsala University, Uppsala, 751 85, Sweden. dimitris.papantoniou@medsci.uu.se.
Publikováno v:
BMC cancer [BMC Cancer] 2023 Apr 04; Vol. 23 (1), pp. 309. Date of Electronic Publication: 2023 Apr 04.
Autor:
Naeser Y; Rudbeck Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, 751 85 Uppsala, Sweden.; Department of Oncology, Uppsala University Hospital, Entrance 101, First Level, 751 85 Uppsala, Sweden., Helgadottir H; Department of Oncology-Pathology, Karolinska Institutet, 171 77 Stockholm, Sweden.; Theme Cancer, Karolinska University Hospital, 171 76 Stockholm, Sweden., Hansson J; Theme Cancer, Karolinska University Hospital, 171 76 Stockholm, Sweden., Ingvar C; Department of Surgery, Clinical Sciences, Lund University, BMC F12, 221 84 Lund, Sweden., Elander NO; Department of Biomedical and Clinical Sciences, Linköping University, 581 85 Linköping, Sweden., Flygare P; Department of Oncology, Sundsvall County Hospital, Lasarettsgatan 21, 856 43 Sundsvall, Sweden., Nilsson C; Department of Oncology, Hospital of Västmanland Västerås, 721 89 Västerås, Sweden., Jakobsson F; Department of Oncology, Örebro University Hospital, 701 85 Örebro, Sweden., Valachis A; Department of Oncology, Faculty of Medicine and Health, Örebro University, 701 82 Örebro, Sweden., Papantoniou D; Department of Oncology, Ryhov County Hospital, 551 85 Jönköping, Sweden., Nordin Danfors A; Department of Oncology, Visby County Hospital, St. Göransgatan 5, 621 84 Visby, Sweden., Johansson H; Department of Oncology-Pathology, Karolinska Institutet, 171 77 Stockholm, Sweden.; Theme Cancer, Karolinska University Hospital, 171 76 Stockholm, Sweden., Sundin A; Department of Surgical Sciences Radiology & Molecular Imaging, Uppsala University, 751 85 Uppsala, Sweden., Brandberg Y; Department of Oncology-Pathology, Karolinska Institutet, 171 77 Stockholm, Sweden., Ullenhag GJ; Rudbeck Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, 751 85 Uppsala, Sweden.; Department of Oncology, Uppsala University Hospital, Entrance 101, First Level, 751 85 Uppsala, Sweden.
Publikováno v:
Cancers [Cancers (Basel)] 2022 Feb 18; Vol. 14 (4). Date of Electronic Publication: 2022 Feb 18.
Autor:
Isaksson J; Department of Oncology, Department of Biomedical and Clinical Sciences, Linköping University, Linköping 58185, Sweden., Green H; Division of Drug Research, Department of Biomedical and Clinical Sciences, Linköping University, Linköping 58185, Sweden., Papantoniou D; Department of Oncology, Ryhov County Hospital, Jönköping 55305, Sweden., Pettersson L; Department of Oncology, Ryhov County Hospital, Jönköping 55305, Sweden., Anden M; Department of Oncology, Kalmar County Hospital, Kalmar 39244, Sweden., Rosell J; Regional Cancer Center Southeast Sweden, Linköping University, Linköping 58185, Sweden., Åvall-Lundqvist E; Department of Oncology, Department of Biomedical and Clinical Sciences, Linköping University, Linköping 58185, Sweden., Elander NO; Department of Oncology, Department of Biomedical and Clinical Sciences, Linköping University, Linköping 58185, Sweden. nils.elander@liu.se.
Publikováno v:
World journal of clinical oncology [World J Clin Oncol] 2021 Nov 24; Vol. 12 (11), pp. 1009-1022.
Autor:
Aughton K; Liverpool Experimental Cancer Medicine Centre, 2nd Floor Sherrington Building, Ashton St, University of Liverpool, Liverpool L69 3GE, UK., Elander NO; Liverpool Experimental Cancer Medicine Centre, 2nd Floor Sherrington Building, Ashton St, University of Liverpool, Liverpool L69 3GE, UK.; Department of Oncology, Linköping University, SE-581 83 Linköping, Sweden., Evans A; Liverpool Experimental Cancer Medicine Centre, 2nd Floor Sherrington Building, Ashton St, University of Liverpool, Liverpool L69 3GE, UK., Jackson R; Liverpool Experimental Cancer Medicine Centre, 2nd Floor Sherrington Building, Ashton St, University of Liverpool, Liverpool L69 3GE, UK., Campbell F; Liverpool Experimental Cancer Medicine Centre, 2nd Floor Sherrington Building, Ashton St, University of Liverpool, Liverpool L69 3GE, UK., Costello E; Liverpool Experimental Cancer Medicine Centre, 2nd Floor Sherrington Building, Ashton St, University of Liverpool, Liverpool L69 3GE, UK., Halloran CM; Liverpool Experimental Cancer Medicine Centre, 2nd Floor Sherrington Building, Ashton St, University of Liverpool, Liverpool L69 3GE, UK., Mackey JR; Cross Cancer Institute, University of Alberta, Edmonton, AB T6G 1Z2, Canada., Scarfe AG; Cross Cancer Institute, University of Alberta, Edmonton, AB T6G 1Z2, Canada., Valle JW; The Christie NHS Foundation Trust, University of Manchester, Manchester M20 4BX, UK., Carter R; Glasgow Royal Infirmary, Glasgow G4 0SF, UK., Cunningham D; Royal Marsden National Health Service (NHS) Foundation Trust, London SW3 6JJ, UK., Tebbutt NC; Austin Health, Melbourne, VIC 3084, Australia., Goldstein D; Prince of Wales Hospital and Clinical School, University of New South Wales, Sydney, NSW 2052, Australia., Shannon J; Nepean Cancer Centre, University of Sydney, Sydney, NSW 2747, Australia., Glimelius B; Department of Immunology, Genetics and Pathology, Uppsala University, SE-751 05 Uppsala, Sweden., Hackert T; Department of Surgery, University of Heidelberg, 69047 Heidelberg, Germany., Charnley RM; Freeman Hospital, Newcastle upon Tyne NE7 7DN, UK., Anthoney A; St James's University Hospital, Leeds LS9 7TF, UK., Lerch MM; Department of Medicine A, University Medicine Greifswald, 17489 Greifswald, Germany., Mayerle J; Department of Medicine A, University Medicine Greifswald, 17489 Greifswald, Germany.; Medizinische Klinik und Poliklinik II, Klinikum der LMU München-Grosshadern, 81377 München, Germany., Palmer DH; Liverpool Experimental Cancer Medicine Centre, 2nd Floor Sherrington Building, Ashton St, University of Liverpool, Liverpool L69 3GE, UK., Büchler MW; Department of Surgery, University of Heidelberg, 69047 Heidelberg, Germany., Ghaneh P; Liverpool Experimental Cancer Medicine Centre, 2nd Floor Sherrington Building, Ashton St, University of Liverpool, Liverpool L69 3GE, UK., Neoptolemos JP; Department of Surgery, University of Heidelberg, 69047 Heidelberg, Germany., Greenhalf W; Liverpool Experimental Cancer Medicine Centre, 2nd Floor Sherrington Building, Ashton St, University of Liverpool, Liverpool L69 3GE, UK.
Publikováno v:
Cancers [Cancers (Basel)] 2021 Nov 17; Vol. 13 (22). Date of Electronic Publication: 2021 Nov 17.
Real-world evidence on first- and second-line palliative chemotherapy in advanced pancreatic cancer.
Autor:
Blomstrand H; Department of Biomedical and Clinical Sciences, Linköping University, Linköping 58185, Sweden., Batra A; Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi 110029, India., Cheung WY; Department of Oncology, University of Calgary, Calgary T2N 4N1, Canada., Elander NO; Department of Biomedical and Clinical Sciences, Linköping University, Linköping 58185, Sweden. nils.elander@liu.se.
Publikováno v:
World journal of clinical oncology [World J Clin Oncol] 2021 Sep 24; Vol. 12 (9), pp. 787-799.